Dr. Bruce Hamory

Blog Entry Image

No, Value-Based Payments Aren't Doomed

Why is the shift to value taking so long? And where are the promised results? There's nothing wrong with the model; the problem is in execution and implementation.

Dr. Bruce Hamory portrait

Dr. Bruce Hamory

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Blog Entry Image

Infographic: Anatomy of the ACO Market

A comprehensive view of the ACO market, including a detailed look at “winners”, regional differences, and success rates by type.

Dr. Bruce Hamory portrait

Dr. Bruce Hamory

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Josh Michelson portrait

Josh Michelson

Partner, Health & Life Sciences, Oliver Wyman
Sarah Kokinos portrait

Sarah Kokinos

Associate, Oliver Wyman
Blog Entry Image

New Analysis: The ACO Landscape Today

Oliver Wyman analysis details the performance of ACOs by type (physician-led, hospital-led, commercial) and offers insight into what it will take for each to be successful.

Dr. Bruce Hamory portrait

Dr. Bruce Hamory

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Josh Michelson portrait

Josh Michelson

Partner, Health & Life Sciences, Oliver Wyman
Blog Entry Image

Value-Based Care Under President-Elect Trump? Here to Stay

Why the path to value remains necessary to offset the high-cost/low-quality formula – no matter who is sitting in the White House.

Dr. Bruce Hamory portrait

Dr. Bruce Hamory

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Dan Shellenbarger portrait

Dan Shellenbarger

Global Head, Provider, Health & Life Sciences, Oliver Wyman